|
" Trends in Inflammatory Bowel Disease Therapy 1999 : "
edited by C.N. Williams, R.F. Bursey, D.G. Gall, F. Martin, R.S. McLeod, L.R. Sutherland, J.L. Wallace.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
730235
|
| Doc. No
|
:
|
b549996
|
| Main Entry
|
:
|
edited by C.N. Williams, R.F. Bursey, D.G. Gall, F. Martin, R.S. McLeod, L.R. Sutherland, J.L. Wallace.
|
| Title & Author
|
:
|
Trends in Inflammatory Bowel Disease Therapy 1999 : : the proceedings of a symposium organized by AXCAN PHARMA, held in Vancouver, BC, August 27-29, 1999\ edited by C.N. Williams, R.F. Bursey, D.G. Gall, F. Martin, R.S. McLeod, L.R. Sutherland, J.L. Wallace.
|
| Publication Statement
|
:
|
Dordrecht: Springer Netherlands, 2000
|
| Page. NO
|
:
|
(xvi, 262 pages)
|
| ISBN
|
:
|
9401140022
|
|
|
:
|
: 9789401140027
|
| Contents
|
:
|
Section I: Genetics --;1 Genetics of Inflammatory bowel disease: where are we? --;2 Genetics of inflammatory bowel disease: why is it important? --;3 Genetics of IBD: impact on immune function --;Section II: Pathogenesis --;4 Bacterial factors in inflammatory bowel disease pathogenesis --;5 Inflammatory bowel disease: autoimmunity or chronic inflammation? --;6 Neutrophil --;epithelial interactions, and efforts to down-regulate them, in inflammatory bowel disease --;7 Understanding inflammatory bowel disease at the millennium: tentative answers and future questions --;Section III: Clinical Challenges in Inflammatory Bowel Disease --;8 Diagnosis of inflammatory bowel disease: an update --;9 Recent developments in the diagnosis and management of paediatric inflammatory bowel disease --;10 Inflammatory bowel disease in the elderly --;Section IV: Current Therapy in Inflammatory Bowel Disease --;11 Induction of remission in ulcerative colitis --;12 Remission maintenance in ulcerative colitis --;13 Induction therapy for Crohn's disease --;14 Maintenance of remission in Crohn's disease --;Section V: Bone Disease in Inflammatory Bowel Disease --;15 Risk factors and prevalence of bone disease in inflammatory bowel disease --;16 Management of low bone mass in patients with inflammatory bowel disease --;17 Steroid-induced osteonecrosis in inflammatory bowel disease: Canadian legal status --;Section VI: Alternative Therapy --;18 Psychotherapy for inflammatory bowel disease: new prospects --;19 The use of complementary and alternative medicine by patients with inflammatory bowel disease --;20 Gut inflammation: is there a role for herbal medicines? --;21 The role of nutrition in the treatment of inflammatory bowel disease --;Section VII: New Therapeutic Approaches --;22 Antibodies to proinflammatory cytokines --;23 Immunomodulation of Crohn's disease --;24 Application of recombinant DNA technology to the identification of novel therapeutic targets in inflammatory bowel disease --;25 The use of probiotics in inflammatory bowel disease.
|
| Abstract
|
:
|
This Trends in Inflammatory Bowel Disease Therapy Symposium was held in Vancouver, British Columbia, Canada, 27~29 August 1999. This is the seventh international symposium, sponsored by Axcan Pharma Canada Inc., since the first symposium in 1986.
|
| Subject
|
:
|
Gastroenterology.
|
| Subject
|
:
|
Medicine.
|
| LC Classification
|
:
|
RC862.I53E358 2000
|
| Added Entry
|
:
|
C N Williams
|
| |